Distalmotion logo — Empowering Access to Robotic Surgery

Distalmotion

Empowering Access to Robotic Surgery

Founded 2012 Switzerland Epalinges, Switzerland 220 employees Series F+ Total: $390.10M Health Care, Health and Wellness +2

General Information

Company Name Distalmotion
Founded Year 2012
Location Switzerland Epalinges, Switzerland
Employees 220
Industries Health Care, Health and Wellness, Medical Devices +1
Funding Stage Series F+
Business Model B2B, Platform
Revenue Model Product Sales, Service Fee, Usage Based
Social

BounceWatch is an independent company data service, not affiliated with Distalmotion. To contact Distalmotion, visit distalmotion.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Distalmotion compare?

A PDF of Distalmotion and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Distalmotion soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Distalmotion

Distalmotion is a pioneering MedTech company established in 2012, based in Lausanne, Switzerland, with an additional U.S. office in Cleveland, Ohio. Its mission, encapsulated in the slogan "Empowering Access to Robotic Surgery_Right Robot, Right Site," is to make robotic surgery benefits more accessible globally, focusing on broadening availability in diverse medical settings like hospital outpatient departments and ambulatory surgical centers.

The company's flagship product, DEXTER, is a versatile robotic system designed for seamless integration into operating rooms of any size. It offers rapid setup and ease of movement, enhancing the efficiency of minimally invasive surgical procedures. DEXTER is already available for commercial use across the United States and Europe.

Recently, Distalmotion secured a substantial €136.94 million Series F investment from Revival Healthcare Capital, a notable indication of investor confidence in its innovative approach to healthcare technology.

Business keywords: Robotic Surgery, Minimally Invasive Care, Medical Device Manufacturer, MedTech, Surgical Robotics, Laparoscopy, Outpatient Surgical Centers, General Surgery, Gynecology Surgery, Urology Surgery, Ambulatory Surgical Centers, Healthcare Innovation, Robotics Integration, Surgical Technology

Services & Products

Robotic Surgery System
Surgical Integration Solutions
Operational Workflow Support

Target Customers

Surgeons Hospitals Outpatient Facilities

Funding Rounds & Investors (8)

View All
Funding Stage Amount Investors Lead Investors Date
Series G $150.00M 1
Revival Healthcare Capital
01 Nov 2025
Late VC Undisclosed 2
Revival Healthcare Capital, Swiss Entrepreneurs Foundation
01 Sep 2024
Growth Equity VC $150.00M 1
Revival Healthcare Capital
01 Apr 2023
Series E $90.00M 2
Revival Healthcare Capital, 415 CAPITAL
01 Jan 2022
Series A Undisclosed 1
Zühlke Ventures AG
01 Aug 2013
Seed Fr.100.00K 1
Venture Kick
01 Mar 2012
Seed Undisclosed 1
Fondation FIT
01 Nov 2011
Spinout Undisclosed 3
University Ventures, EPFL Swiss Federal Institute of Technology in Lausanne +1
01 Jan 2011

Distalmotion Alternatives & Competitors

View All Alternatives
Distalmotion vs
Virtual Incision
Virtual Incision United States

Introducing the World’s First Miniaturized Robotic-Assisted Surgery (RAS) System. Follow us for upda...

Series C
33 employees
Health Care, Manufacturing
Distalmotion vs
Andromeda Surgical
Andromeda Surgical United States

Autonomous robots to make surgery safer, easier, and more efficient

Seed
12 employees
Manufacturing, Medical Devices
Distalmotion vs
CMR Surgical
CMR Surgical United Kingdom

Transforming surgery. For good.

679 employees
Health Care, Medical Devices

FAQ About Distalmotion

Empowering Access to Robotic Surgery
Distalmotion was founded in 2012.
Distalmotion is headquartered in Epalinges, Switzerland.
Distalmotion operates in Health Care, Health and Wellness, Medical Devices and Robotics. Its work centres on Robotic Surgery, Minimally Invasive Care, Medical Device Manufacturer and MedTech. Its customers include Surgeons, Hospitals and Outpatient Facilities.
Distalmotion has a B2B and Platform business model. Its revenue comes from Product Sales, Service Fee and Usage Based.
Distalmotion has approximately 220 employees.
Distalmotion has completed 8 funding rounds, raising a total of $390.10M. The latest funding stage is Series F+.
Distalmotion offers: Robotic Surgery System, Surgical Integration Solutions, Operational Workflow Support.
Top alternatives and competitors to Distalmotion include Virtual Incision, Andromeda Surgical, CMR Surgical, EndoRobotics Co., Ltd., Beijing Remebot Technology Co., Ltd.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Distalmotion and Virtual Incision are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Distalmotion, https://bouncewatch.com/company/distalmotion, updated 25 September 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes